Calithera Biosciences Inc 's

• CALA's Stock Performance relative to its Competitors

Crescent Biopharma Inc Share Performance -16.38% 30 Days

Crescent Biopharma Inc Profile The company is a clinical-stage biotechnology firm focused on developing PD-1 x VEGF bispecific antibodies and antibody-drug conjugates for cancer treatment. More about Crescent Biopharma Inc 's Market Share

Ensysce Biosciences Inc Share Performance -7.48% Over The Past 5 Days

Ensysce Biosciences Inc Profile Ensysce Biosciences Inc is a biopharmaceutical company that operates on a business model centered around developing and commercializing novel therapies using their proprietary drug delivery technology, known as MedXPRESS™. This technology allows for precise control of drug release and enhanced delivery to target tissues, with a focus on improving therapeutic outcomes and patient compliance. More about Ensysce Biosciences Inc 's Market Share

Galectin Therapeutics Inc Share Performance -14.74% One Year

Galectin Therapeutics Inc Profile Galectin Therapeutics Inc is a biotechnology company that focuses on developing therapies for fibrotic diseases and cancer by targeting galectin proteins. Their business model involves conducting research and development to create novel galectin-targeting drugs, partnering with pharmaceutical companies for joint development and commercialization, and potentially seeking regulatory approval for their products to enter the market. They generate revenue through licensing agreements, collaborations, and potential sales of their developed therapies. More about Galectin Therapeutics Inc 's Market Share

Invivo Therapeutics Holdings Corp Share Performance -84.73% One Year

Invivo Therapeutics Holdings Corp Profile Invivo Therapeutics Holdings Corp is a biotherapeutics and biomaterials company. Their business model focuses on developing and commercializing treatment options for patients with spinal cord injuries. They aim to provide novel solutions through the development of innovative technologies and therapies in the field of neurological disorders. More about Invivo Therapeutics Holdings Corp 's Market Share

Nymox Pharmaceutical Corporation Share Performance -49.37% 30 Days

Nymox Pharmaceutical Corporation Profile Nymox Pharmaceutical Corporation is a biopharmaceutical company focused on the research and development of innovative treatments for various diseases and conditions. More about Nymox Pharmaceutical Corporation's Market Share

Sources: Calithera Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, September 18, 2026 1:11 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Calithera Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.